Association of Industry Payments and Botulinum Toxin Brand Use Among Physiatrists Treating Spasticity
PM&R · 2026-11 · 18 (S3)
DOI: 10.1002/pmrj.7_70259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Daniel Pierce und 3 weiteren Autor:innen.
Abstract (Originalsprache)
No financial relationships to disclose Background and/or Objectives: Adverse Childhood Experiences (ACEs) are associated with chronic pain, psychological distress, and poorer health outcomes.However, the impact of ACE burden on outcomes following multidisciplinary pain rehabilitation remains unclear.This study evaluated whether ACE scores are associated with baseline symptom severity and treatment outcomes among patients participating in a comprehensive pain rehabilitation program.
Design
Retrospective cohort study evaluating the association between ACE and treatment outcomes among patients undergoing multidisciplinary pain rehabilitation.
Setting
Multidisciplinary Pain Rehabilitation Center (PRC) at a tertiary academic medical center.
Participants
A total of 985 adult patients with chronic pain who completed the PRC program.
Interventions
Comprehensive multidisciplinary pain rehabilitation program incorporating physical rehabilitation, behavioral therapy, pain education, and medication optimization.Main Outcome Measures: Changes from admission to discharge in depression (CES-D), pain catastrophizing (PCS), and health-related quality of life (SF-36 domains).Clinically meaningful improvement was defined using established minimally clinically important differences (MCIDs): ≥9 points for CES-D, ≥3.2 points for PCS, and ≥5 points for SF-36 domains.
Results
Patients with high ACE scores had worse baseline depression, pain catastrophizing, and several SF-36 domains compared with the low ACE group (P
Zitieren
APA
Pierce, D., Harrington, C., Woods, A., & Schneider, S. (2026). Association of Industry Payments and Botulinum Toxin Brand Use Among Physiatrists Treating Spasticity. PM&R, 18(S3). https://doi.org/10.1002/pmrj.7_70259
Vancouver
Pierce D, Harrington C, Woods A, Schneider S. Association of Industry Payments and Botulinum Toxin Brand Use Among Physiatrists Treating Spasticity. PM&R. 2026;18(S3). doi:10.1002/pmrj.7_70259
BibTeX
@article{Pierce2026,
author = {Pierce, Daniel and Harrington, Creighton and Woods, Anna and Schneider, Sonia},
title = {Association of Industry Payments and Botulinum Toxin Brand Use Among Physiatrists Treating Spasticity},
journal = {PM&R},
year = {2026},
volume = {18},
number = {S3},
doi = {10.1002/pmrj.7_70259}
}
EUVIMED